GUSELKUMAB EFFICACY IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS BY BASELINE DEMOGRAPHIC AND DISEASE CHARACTERISTICS: POOLED RESULTS OF TWO PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDIES

被引：0

作者：

Deodhar, Atul ^{[1
]}

Mease, Philip J. ^{[2
,3
]}

Boencke, Wolf-Henning ^{[4
]}

Tesser, John ^{[5
]}

Schiopu, Elena ^{[6
]}

Chakravarty, Soumya D. ^{[7
,8
]}

Kollmeier, Alexa P. ^{[9
]}

Hsia, Elizabeth C. ^{[9
,10
]}

Xu, Xie L. ^{[9
]}

Shawi, May ^{[11
]}

Jiang, Yusang ^{[9
]}

Sheng, Shihong ^{[9
]}

Agarwal, Prasheen ^{[9
]}

Merola, Joseph F. ^{[12
]}

McInnes, Iain B. ^{[13
]}

Ritchlin, Christopher T. ^{[14
]}

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Swedish Med Ctr, Providence St Joseph Hlth, Seattle, WA USA

[3] Univ Washington, Seattle, WA 98195 USA

[4] Geneva Univ Hosp, Geneva, Switzerland

[5] Arizona Arthrit & Rheumatol Associates, Phoenix, AZ USA

[6] Michigan Med Rheumatol Clin, Ann Arbor, MI USA

[7] Janssen Sci Affairs LLC, Horsham, PA USA

[8] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[9] Janssen Res & Dev LLC, Spring House, PA USA

[10] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA

[11] Janssen Global Serv LLC, Horsham, PA USA

[12] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA

[13] Univ Glasgow, Glasgow, Lanark, Scotland

[14] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2021年 / 27卷

关键词：

BIOLOGIC-NAIVE; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PANLAR2021

引用

页码：S108 / S109

页数：2

共 50 条

[31] Bimekizumab improves joint measures in patients with active psoriatic arthritis and moderate or severe psoriasis: Pooled 16-week results from phase 3 randomized, placebo-controlled studies BE OPTIMAL and BE COMPLETE
Gottlieb, Alice B.
Asahina, Akihiko
Merola, Joseph F.
McInnes, Iain B.
Boehncke, Wolf-Henning
Lebwohl, Mark
Thaci, Diamant
Ink, Barbara
Bajracharya, Rajan
Coarse, Jason
Warren, Richard B.
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB128 - AB128
[32] EFFICACY AND SAFETY RESULTS OF GUSELKUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OVER 56 WEEKS FROM A PHASE 2A, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Deodhar, A.
Gottlieb, A. B.
Boehricke, W-H.
Dong, B.
Wang, Y.
Zhuang, Y.
Barchuk, W.
Xu, X. L.
Hsia, E.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 201 - 201
[33] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
Philip J. Mease
Ana-Maria Orbai
Oliver FitzGerald
Mohamed Bedaiwi
Rajiv Dona L. Fleishaker
Pamela Mundayat
Philip S. Young
[J]. Arthritis Research & Therapy, 25
[34] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
Mease, Philip J.
Orbai, Ana-Maria
FitzGerald, Oliver
Bedaiwi, Mohamed
Fleishaker, Dona L.
Mundayat, Rajiv
Young, Pamela S.
Helliwell, Philip
[J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[35] Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III Trial
Kavanaugh, Arthur
Puig, Lluis
Gottlieb, Alice B.
Ritchlin, Christopher
Li, Shu
Wang, Yuhua
Mendelsohn, Alan M.
Song, Michael
Zhu, Yaowei
Rahman, Proton
Mcinnes, Iain B.
[J]. ARTHRITIS CARE & RESEARCH, 2015, 67 (12) : 1739 - 1749
[36] Stringent Disease Activity Control at 2 Years Across Psoriatic Arthritis Domains Irrespective of Baseline Characteristics in Patients Treated with Guselkumab: Post Hoc Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study
Ritchlin, Christopher
Mease, Philip J.
Boehncke, Wolf-Henning
Tesser, John
Chakravarty, Soumya
Rampakakis, Emmanouil
Shawi, May
Schiopu, Elena
Merola, Joseph
McInnes, Iain B.
Deodhar, Atul
[J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4178 - 4182
[37] Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic DMARD-Naive or TNFi-IR Patients with Active Psoriatic Arthritis: Pooled 16-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
Husni, M. Elaine
Mease, Philip J.
Merola, Joseph
Behrens, Frank
Favalli, Ennio Giulio
McGonagle, Dennis
Tillett, William
Tsuji, Shigeyoshi
Ink, Barbara
Assudani, Deepak
Bajracharya, Rajan
Coarse, Jason
Lambert, Jeremy
Gossec, Laure
[J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4197 - 4199
[38] Efficacy and safety of guselkumab, an anti-IL23 Monoclonal antibody, in patients with active psoriatic arthritis: A phase 2a, randomized, double-blind, placebo-controlled study
Gottlieb, Alice
Deodhar, Atul
Boehncke, Wolf-Henning
Dong, Bin
Wang, Yuhua
Barchuk, William
Hsia, Elizabeth
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB111 - AB111
[39] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Nash, Peter
Mease, Philip J.
McInnes, Iain B.
Rahman, Proton
Ritchlin, Christopher T.
Blanco, Ricardo
Dokoupilova, Eva
Andersson, Mats
Kajekar, Radhika
Mpofu, Shephard
Pricop, Luminita
[J]. ARTHRITIS RESEARCH & THERAPY, 2018, 20
[40] Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)
Peter Nash
Philip J. Mease
Iain B. McInnes
Proton Rahman
Christopher T. Ritchlin
Ricardo Blanco
Eva Dokoupilova
Mats Andersson
Radhika Kajekar
Shephard Mpofu
Luminita Pricop
[J]. Arthritis Research & Therapy, 20

← 1 2 3 4 5 →